Last fall, a new season began with a crucial difference: for the first time, doctors had tools to protect the youngest babies from RSV. Parents could either get a new antibody shot for their infant after birth or get vaccinated themselves during pregnancy to pass on protection. A new report takes a first look at how many infants born from October 2023 through March 2024 in the United States received one of these forms of immunization. The report does not share the actual coverage numbers, safety information, or how well the protection worked. It simply marks the start of tracking this important public health effort. Since this is an early observational report, it doesn't tell us why some families might have gotten the protection and others didn't, or what the barriers to access might be. It's a starting point for understanding how these new tools are being used to guard babies against a serious virus.
How many infants are getting new RSV protection? A first look.
Photo by Navy Medicine / Unsplash
What this means for you:
First snapshot of new RSV protection for infants shows tracking has begun. More on Respiratory Syncytial Virus Infection
RSV disease severity compared to COVID-19 and influenza in hospitalized older adults Study compares RSV severity to COVID-19 and flu in hospitalized older adults
CDC · Apr 5, 2026
Field report describes nirsevimab rollout for RSV prevention in New York City infants How many New York City infants got the new RSV shot this season?
CDC · Apr 4, 2026
Narrative review on pediatric RSV co-infections and post-pandemic rebound RSV Hits Kids Harder When Another Bug Joins In
Frontiers · Apr 24, 2026
US adult vaccination coverage for influenza, COVID-19, and RSV reported in observational data How many eligible adults are getting their flu, COVID, and RSV shots?
CDC · Apr 5, 2026